# Eli Lilly beats estimates, raises sales outlook as Zepbound and Mounjaro demand surges again

https://mins.news/en/item/120697

- CNBC, 2026-10-29 11:44 UTC
- Economy
- Original: https://www.cnbc.com/2026/10/29/eli-lilly-lly-earnings-q3-2026.html

> Eli Lilly said sales of its obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter. The company beat estimates and raised its sales outlook.

## Related coverage

- [Eli Lilly raises revenue outlook as weight-loss injections offset Foundayo shortfall](https://mins.news/en/item/120955) — Reuters, 2026-10-29